Back to Journals » Drug Design, Development and Therapy » Volume 11

Review

Sodium-glucose cotransporter 2 inhibitors combined with dipeptidyl peptidase-4 inhibitors in the management of type 2 diabetes: a review of current clinical evidence and rationale

          
Total article views   Abstract views HTML views PDF downloads Totals
10,619 Dovepress* 6,771 2,464+ 1,288 9,235
PubMed Central* 0 1,384 308 1,384
Totals 6,771 3,848 1,596 10,619
*Since 21 March 2017
+Since July 2016

View citations on PubMed Central and Google Scholar